IRIS
PRONZATO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.669
AS - Asia 18
SA - Sud America 1
Totale 2.688
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.668
CN - Cina 16
SG - Singapore 2
AR - Argentina 1
RO - Romania 1
Totale 2.688
Salva come PNG Salva come JPEG
Città #
Genova 1.145
Genoa 967
Rapallo 304
Vado Ligure 247
Beijing 5
Bordighera 5
Satu Mare 1
Singapore 1
Totale 2.675
Salva come PNG Salva come JPEG
Nome #
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 163
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 143
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 141
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 137
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 131
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 127
Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives 119
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 118
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors 118
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 112
Medical approaches to preservation of fertility in female cancer patients 108
Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors 106
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group 105
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 102
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 99
Use in current clinical practice of 70-gene signature in early breast cancer 97
Stevens-johnson syndrome after treatment with bendamustine 97
Economic Impact of Inter-Regional Health Mobility In The Oldest European Administrative Region: A Starting Point For Changing Organizational Model? 95
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients. 92
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: Extending endocrine sensitivity 91
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. 84
Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients 82
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 65
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria 47
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study 40
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors 38
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 36
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy 29
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study 28
The Impact of the Introduction of the Breast Unit Model in a Northwestern Italian Region 27
The Ligurian Experience in the Management of Lung Cancer: Organizational Models and New Perspectives 7
Totale 2.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.488
article - articoli 11.488
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 36 9 8 12 22 9 25 9 15
2021/2022229 12 10 9 27 3 31 4 48 22 29 7 27
2022/2023344 25 37 5 22 65 53 4 40 57 10 25 1
2023/2024180 6 23 3 28 16 9 29 8 7 10 7 34
2024/2025693 30 42 15 38 78 73 54 131 27 37 70 98
2025/2026352 157 35 83 77 0 0 0 0 0 0 0 0
Totale 2.784